headerphoto

B-4474 (Wound Infections)

The active ingredient of B-4474 is a harmless, recombinant bacterium that is able to conjugate with and kill Gram negative bacteria. To ensure safety, the bacterium is engineered to not survive. It survives only long enough to be applied to the wound and to kill the pathogenic bacteria.

ConjuGon has extensive in vitro and in vivo data demonstrating the ability of this recombinant bacterium to kill all Gram negative pathogens including strains that are pan-resistant.

Latest News

news 23 Apr 2009
FDA Accepts IND for ConjuGon’s C-1205 — Prevention of Urinary Tract Infections

news 23 Oct 2008
ConjuGon to Receive $2.4 Million for Defense R&D

news 05 Dec 2007
ConjuGon to Receive $1.2 Million from Department of Defense